[1]
C. Kouanfack, “Clinical, Biochemical and CT-Scan Characteristics of Obesity Onset in Patients Under Dolutegravir in Comparison With Low-Dose-Efavirenz: A Pilot Study in Cameroon”, Health Sci. Dis., vol. 22, no. 3, Feb. 2021.